Validation of the WINROP screening algorithm among preterm infants in East Malaysia
Abstract
Objective: To prospectively validate the WINROP (Weight, Insulin-like growth factor 1, Neonatal, Retinopathy of Prematurity) screening algorithm (www.winrop.com) based on longitudinal measurements of neonatal body weights in predicting the development of severe retinopathy of prematurity (ROP) among preterm infants admitted to the neonatal intensive care unit of a tertiary care center in East Malaysia.
Methods: All premature infants of less than 32 weeks gestational age (GA) were included in this cohort. Their body weight was measured weekly from birth to 36 weeks postmenstrual age and entered into the computer-based surveillance system: WINROP. Infants were then classified by the system into high- or low-risk alarm group. The retinopathy findings were recorded according to Early Treatment for ROP criteria. However, the screening and management of infants were done according to the recommendations of the Continuous Practice Guidelines, Ministry of Health, Malaysia. The team members involved in screening and those recording the findings were kept blinded from each other.
Results: A total of 151 infants with median GA at birth of 30 weeks (interquartile range [IQR] Å} 2.1) and mean birth weight of 1,264 g (standard deviation Å} 271) were analyzed. High-risk alarm was signaled in 85 (56.3%) infants and 9 (6.6%) infants developed type 1 ROP. One infant in the low-risk alarm group developed type 1 ROP requiring laser retinal photocoagulation. The median time lag from the high-risk alarm signal to the development of type 1 ROP was 10.4 (IQR Å} 8.4) weeks.
Conclusion: In this cohort, the WINROP algorithm had a sensitivity of 90%, with negative predictive value of 98.5% (95% confidence interval) for detecting infants with type 1 ROP and was able to predict infants with ROP earlier than their due screening date. This study shows that a modified version of the WINROP algorithm aimed at specific populations may improve the outcome of this technique.
References
Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol. 2001;119:1110-1118.
Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684-1694.
Choo MM, Martin FJ, Theam LC, et al. Retinopathy of prematurity in extremely low birth weight infants in Malaysia. J AAPOS. 2009;13:446-449.
Rahi JS, Cable N. Severe visual impairment and blindness in children in the UK. Lancet. 2003;362:1359-1365.
Laws DE, Morton C, Weindling M, et al. Systemic effects of screening for retinopathy of prematurity. Br J Ophthalmol. 1996;80:425-428.
Mitchell AJ, Green A, Jeffs DA, et al. Physiologic effects of retinopathy of prematurity screening examinations. Adv Neonatal Care. 2011;11:291-297.
Löfqvist C, Andersson E, Sigurdsson J, et al. Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. Arch Ophthalmol. 2006;124:1711-1718.
Löfqvist C, Hansen-Pupp I, Andersson E, et al. Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I. Arch Ophthalmol. 2009;127:622-627.
Hellstrom A, Hard AL, Engstrom E, et al. Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening. Pediatrics. 2009;123:e638-e645.
Wu C, Vanderveen DK, Hellström A, et al. Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity. Arch Ophthalmol. 2010;128:443-447.
Wu C, Löfqvist C, Smith LE, et al; WINROP Consortium. Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity. Arch Ophthalmol. 2012;130:992-999.
Hård A, Löfqvist C, Fortes Filho JB, et al. Predicting proliferative retinopathy in a Brazilian population of preterm infants with the screening algorithm WINROP. Arch Ophthalmol. 2010;128:1432-1436.
Choi J, Löfqvist C, Hellström A, et al. Efficacy of the screening algorithm WINROP in a Korean population of preterm infants. JAMA Ophthalmol. 2013;131:62-66.
Sun H, Kang W, Cheng X, et al. The use of the WINROP screening algorithm for the prediction of retinopathy of prematurity in a Chinese population. Neonatology. 2013;104:127-132.
Ballard JL, Khoury JC, Wedig K. New Ballard Score, expanded to include extremely premature infants. J Pediatr. 1991;119:417-423.
Malaysia Clinical Practice Guidelines for Retinopathy of Prematurity 2005. Available from: http://www.acadmed.org.my/index.cfm?&menuid=67
Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123:991-999.
Hack M, Fanaroff AA. Outcomes of children of extremely low birthweight and gestational age in the 1990s. Semin Neonatol. 2000;5:89-106.
Blenow M, Ewald U, Fritz T, et al. One-year survival of extremely preterm infants after active perinatal care in Sweden. J Am Med Assoc. 2009;301:2225-2233.
Slevin M, Murphy J, Daly L, et al. Retinopathy of prematurity screening, stress related responses, the role of nesting. Br J Ophthalmol. 1997;81:762-764.
Chen J, Stahl A, Hellstrom A, et al. Current update on retinopathy of prematurity: screening and treatment. Curr Opin Pediatr. 2011;23:173-178.
Salvin JH, Lehman SS, Jin J, et al. Update on retinopathy of prematurity: treatment options and outcomes. Curr Opin Ophthalmol. 2010;21:329-334.
Copyright (c) 2019 Nurhayati Abdul Kadir, Syed Shoeb Ahmad, Shuaibah Abdul Ghani, Mae-Lyn Catherine Bastion
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication, with the work twelve (12) months after publication simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
